Codes / ICD10CM / C30

C30 Malignant neoplasm of nasal cavity and middle ear

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of nasal cavity and middle ear
  • Nasal cavity and middle ear cancer

Summary

Malignant neoplasm of the nasal cavity and middle ear refers to cancerous growths originating in the nasal passages or middle ear structures. This condition is a type of head and neck cancer that can affect breathing, hearing, and facial function if untreated. It may spread to nearby tissues or lymph nodes.

Causes

The exact cause involves genetic mutations in nasal cavity or middle ear tissue leading to uncontrolled cell growth. Contributing factors may include environmental exposures and genetic predispositions.

Risk Factors

  • Tobacco use (smoking or smokeless)
  • Heavy alcohol consumption
  • Human papillomavirus (HPV) infection
  • Occupational exposure to wood dust or chemicals
  • Chronic sinusitis or nasal polyps
  • Age, particularly over 50
  • Male gender
  • History of other head and neck cancers

Symptoms

  • Persistent nasal congestion or blockage
  • Nosebleeds or facial pain
  • Reduced hearing or ear fullness
  • Facial numbness or swelling
  • Unexplained weight loss
  • Difficulty breathing through the nose
  • Discharge or sores in the nasal cavity

Diagnosis

Diagnosis involves a physical examination by a healthcare provider, followed by a biopsy of the nasal cavity or middle ear tissue to confirm malignancy. Imaging tests such as MRI, CT scans, or PET scans may be used to assess the extent of the cancer and check for spread to other areas.

Treatment Options

Treatment depends on the cancer's stage, location, and patient health. Options may include surgery to remove the tumor, radiation therapy to target cancer cells, chemotherapy to destroy remaining cells, or a combination of these approaches. Targeted therapy or immunotherapy may be considered for specific cases.

Prognosis and Follow-Up

Prognosis varies based on the cancer's stage, location, and response to treatment. Early detection improves outcomes. Regular follow-up appointments are essential to monitor for recurrence, manage side effects, and address long-term complications. Survival rates depend on individual factors and treatment effectiveness.

Complications

Potential complications include tumor spread to nearby structures (e.g., sinuses, brain), hearing loss, facial nerve damage, chronic sinus infections, or difficulty breathing. Treatment-related side effects (e.g., radiation-induced tissue damage, chemotherapy toxicity) may also occur.

Lifestyle & Prevention

  • Avoid tobacco use and limit alcohol consumption
  • Use protective equipment in occupational settings with dust or chemical exposure
  • Manage chronic sinus conditions promptly
  • Practice good nasal hygiene
  • Stay up-to-date with recommended health screenings

When to Seek Professional Help

Seek medical attention if you experience persistent nasal congestion, unexplained nosebleeds, facial pain, hearing changes, or other concerning symptoms. Early evaluation is critical for timely diagnosis and treatment.

Tips for Medical Coders

Use code C30 for malignant neoplasms of the nasal cavity and middle ear. Ensure documentation specifies the exact site (e.g., nasal cavity vs. middle ear) and confirms malignancy. Code to the highest level of specificity available, and verify no other codes (e.g., for metastasis) are required. Review clinical notes for details on tumor location, histology, and staging to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

C30 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.